BioGaia AB (BGLAF)
BioGaia Market Cap : 1.193B for Feb. 5, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Orexo AB | 112.10M |
| BioInvent International AB | 216.40M |
| Hansa Biopharma AB | 290.20M |
| BioArctic AB | 2.937B |
| Camurus AB | 4.232B |
Market Cap Related Metrics
| PE Ratio | 38.32 |
| PS Ratio | 8.263 |
| Price to Book Value | 9.212 |
| Price to Free Cash Flow | 37.57 |
| Price | 11.79 |
| Earnings Yield | 2.61% |
| Operating PE Ratio | 29.09 |
| Normalized PE Ratio | 38.32 |